Results 11 to 20 of about 577 (113)

Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial

BJS (British Journal of Surgery), Volume 107, Issue 13, Page 1791-1800, December 2020., 2020
Remnant cancer missed by endoscopic biopsies was located in the mucosa in two‐thirds of patients with residual disease after neoadjuvant chemoradiotherapy (nCRT). One‐third of patients had residual disease in the submucosa underneath a tumour‐free mucosa. The yield of biopsies in active surveillance after nCRT could be improved by sampling larger areas
B. J. van der Wilk, B. M. Eyck, M. Doukas, M. C. W. Spaander, E. J. Schoon, K. K. Krishnadath, L. E. Oostenbrug, S. M. Lagarde, B. P. L. Wijnhoven, L. H. J. Looijenga, K. Biermann, J. J. B. van Lanschot   +11 more
wiley   +1 more source

Radioterapia de Intensidad modulada versus radioterapia tridimensional en pacientes con cáncer de esófago inoperable: Resultados clínicos, toxicidades y análisis dosimétrico

Revista Methodo, 2023
INTRODUCCIÓN: El cáncer de esófago (CE) es una enfermedad severa, sin embargo, hay un porcentaje de pacientes con enfermedad locorregional que son potencialmente curables.
Gomez Palacios A M, Pérez Conci O, Caussa L, Díaz Vázquez M F, Brun L, Raiden B, Fernández D, Ferraris G   +7 more
doaj   +1 more source

Geographical differences in cancer treatment and survival for patients with oesophageal and gastro‐oesophageal junctional cancers

BJS (British Journal of Surgery), Volume 107, Issue 11, Page 1500-1509, October 2020., 2020
This national cohort study of 5959 patients with oesophageal and gastro‐oesophageal junction (GOJ) cancer showed improved survival for patients in counties with a higher rate of treatment with curative intent and higher resection rate. Explanation needed Background Only around one‐quarter of patients with cancer of the oesophagus and the gastro ...
C. Jestin Hannan, G. Linder, C.‐H. Kung, J. Johansson, M. Lindblad, J. Hedberg   +5 more
wiley   +1 more source

Physiological performance and inflammatory markers as indicators of complications after oesophageal cancer surgery

BJS Open, Volume 4, Issue 5, Page 840-846, October 2020., 2020
C‐reactive protein concentration and peak oxygen uptake are collective independent risk factors that can account for over half of major morbidity following oesophagectomy for oesophageal cancer. A composite risk score, the Combined Inflammatory and Physiology Score (CIPS) (range 0–2), predicted major morbidity (17·9 per cent in patients with a CIPS of ...
A. G. M. T. Powell, C. Eley, T. Abdelrahman, A. H. Coxon, C. Chin, I. Appadurai, R. Davies, D. M. Bailey, W. G. Lewis   +8 more
wiley   +1 more source

Minimally invasive techniques for transthoracic oesophagectomy for oesophageal cancer: systematic review and network meta‐analysis

BJS Open, Volume 4, Issue 5, Page 787-803, October 2020., 2020
Minimally invasive and robotic techniques for oesophagectomy are associated with reduced perioperative morbidity and length of hospital stay, with no compromise of oncological outcomes but no improvement in perioperative mortality. There are suggestions of improved long‐term survival with minimally invasive oesophagectomy and robotic minimally invasive
K. Siaw‐Acheampong, S. K. Kamarajah, R. Gujjuri, J. R. Bundred, P. Singh, E. A. Griffiths   +5 more
wiley   +1 more source

Thromboembolic and bleeding complications in patients with oesophageal cancer

BJS (British Journal of Surgery), Volume 107, Issue 10, Page 1324-1333, September 2020., 2020
A total of 511 patients who underwent curative chemoradiotherapy and subsequent tumour resection for oesophageal cancer were reviewed retrospectively for bleeding events and arterial or venous thromboembolism (VTE). During the 2‐year follow‐up, 50 patients (9·8 per cent) developed VTE, 20 (3·9 per cent) arterial thromboembolism, 21 (4·1 per cent) major
F. I. Mulder, A. Hovenkamp, H. W. M. van Laarhoven, H. R. Büller, P. W. Kamphuisen, M. C. C. M. Hulshof, M. I. van Berge Henegouwen, S. Middeldorp, N. van Es   +8 more
wiley   +1 more source

Manejo actualizado en el tratamiento quirúrgico del cáncer de esófago

Revista de la Facultad de Medicina Humana, 2018
Introducción: El tratamiento quirúrgico del cáncer de esófago sigue siendo un desafío a pesar de los avances en técnica quirúrgica, cuidados pre, post operatorios y complicaciones postoperatorias. Objetivo: Diagnosticar y dar el manejo actualizado en el
Filomeno Teodoro Jáuregui-Francia, Lissette Jáuregui-Caycho, María del Rosario Figueroa-Bejarano, María del Rosario Jáuregui-Figueroa, Juan Miguel Purilla-Janto   +4 more
doaj   +3 more sources

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy

BJS Open, Volume 4, Issue 4, Page 593-600, August 2020., 2020
Following propensity adjustment for stage, age and sex, neoadjuvant therapy was not associated with survival. Tumour regression is a powerful prognostic indicator, and future research should focus on identifying patients who will derive the most benefit from neoadjuvant chemotherapy.
A. G. M. T. Powell, A. Karran, P. Blake, A. Christian, S. A. Roberts, W. G. Lewis   +5 more
wiley   +1 more source

Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review

BJS Open, Volume 4, Issue 4, Page 554-562, August 2020., 2020
This article provides a systematic review of analysis by vibrational spectroscopy (VS) of human blood for cancer diagnosis – a spectral ‘liquid biopsy’. VS showed high potential for cancer diagnosis, but standardized reporting methods and more robust studies are needed before its value in clinical practice can be determined.
D. J. Anderson, R. G. Anderson, S. J. Moug, M. J. Baker   +3 more
wiley   +1 more source

Prognostic and predictive values of tumour budding in stage IV colorectal cancer

BJS Open, Volume 4, Issue 4, Page 693-703, August 2020., 2020
In stage IV colorectal cancer, tumour budding graded by International Tumor Budding Consensus Conference criteria is an important morphological marker that can predict prognosis and, possibly, tumour chemoresistance. The clinical relevance was maintained consistently in both resection subgroups (R0/R1 and R2/unresected).
K. Nagata, E. Shinto, M. Yamadera, T. Shiraishi, Y. Kajiwara, K. Okamoto, S. Mochizuki, K. Hase, Y. Kishi, H. Ueno   +9 more
wiley   +1 more source